Investment Q&A

• Intuitive Surgical Inc. (ISRG $482.22)
  • $482.22 P/E (TTM): 58.18X Cap: $170.78B
  • View ISRG Profile
  • View Questions on ISRG
• Vertex Pharmaceuticals Incorporated (VRTX $430.29)
  • $430.29 P/E (TTM): 28.46X Cap: $109.49B
  • View VRTX Profile
  • View Questions on VRTX
• AbbVie Inc. (ABBV $198.71)
  • $198.71 P/E (TTM): 85.15X Cap: $351.47B
  • View ABBV Profile
  • View Questions on ABBV
• Johnson & Johnson (JNJ $227.50)
  • $227.50 P/E (TTM): 20.91X Cap: $547.64B
  • View JNJ Profile
  • View Questions on JNJ
• Eli Lilly and Company (LLY $883.96)
  • $883.96 P/E (TTM): 39.98X Cap: $835.18B
  • View LLY Profile
  • View Questions on LLY
• Merck & Company Inc. (MRK $111.90)
  • $111.90 P/E (TTM): 15.74X Cap: $276.53B
  • View MRK Profile
  • View Questions on MRK
• iShares Biotechnology ETF (IBB $169.78)
  • $169.78 P/E (TTM): 20.63X Cap: $8.15B
  • View IBB Profile
  • View Questions on IBB
• IDEXX Laboratories Inc. (IDXX $565.93)
  • $565.93 P/E (TTM): 42.88X Cap: $45B
  • View IDXX Profile
  • View Questions on IDXX
• Halozyme Therapeutics Inc. (HALO $65.36)
  • $65.36 P/E (TTM): 26.32X Cap: $7.74B
  • View HALO Profile
  • View Questions on HALO
• Incyte Corporation (INCY $94.65)
  • $94.65 P/E (TTM): 14.89X Cap: $18.83B
  • View INCY Profile
  • View Questions on INCY
• Catalyst Pharmaceuticals Inc. (CPRX $27.37)
  • $27.37 P/E (TTM): 16.38X Cap: $3.34B
  • View CPRX Profile
  • View Questions on CPRX
• Gilead Sciences CDR (CAD Hedged) (GILD $26.60)
  • $26.60 P/E (TTM): 19.71X Cap: $221.78B
  • View GILD Profile
  • View Questions on GILD

Q: We have accumulated 11 healthcare stocks and 1 ETF, While LLY and ISRG are at half positions the rest are at initial 25% positions. Please advise [help!] us get to a more concentrated portfolio with a 3+ year horizon for reasonable opportunities in healthcare

Upvote 6

Read Answer Asked by sam on January 13, 2026

• Vertex Pharmaceuticals Incorporated (VRTX $430.29)
  • $430.29 P/E (TTM): 28.46X Cap: $109.49B
  • View VRTX Profile
  • View Questions on VRTX
• CRISPR Therapeutics AG (CRSP $48.79)
  • $48.79 Cap: $4.70B
  • View CRSP Profile
  • View Questions on CRSP

Q: What is your opinion regarding the future of CRSP? Buy, sell, hold?

Upvote 2

Read Answer Asked by Judith on May 21, 2025

• Vertex Pharmaceuticals Incorporated (VRTX $430.29)
  • $430.29 P/E (TTM): 28.46X Cap: $109.49B
  • View VRTX Profile
  • View Questions on VRTX

Q: May I please get your thoughts on this company? I like their new non-opioid pain killer that was just approved by the FDA for a strong growth prospect. I am curious what you think about the existing business and the fundamentals/financials of the company. Thanks.

Upvote 2

Read Answer Asked by Marco on February 14, 2025

• Vertex Pharmaceuticals Incorporated (VRTX $430.29)
  • $430.29 P/E (TTM): 28.46X Cap: $109.49B
  • View VRTX Profile
  • View Questions on VRTX

Q: Hi 5i,

Would you please provide your opinion on Vertex Pharmaceuticals (VRTX) as a 3-5 year investment.

Does their recent announcement related to an FDA approved non-addictive, non-opioid painkiller have promise?

If so, what would be the longer term implications for the company?

Thanks.

Upvote 4

Read Answer Asked by Brian on February 07, 2025

• Amgen Inc. (AMGN $344.55)
  • $344.55 P/E (TTM): 24.5X Cap: $185.94B
  • View AMGN Profile
  • View Questions on AMGN
• Biogen Inc. (BIIB $184.38)
  • $184.38 P/E (TTM): 21.33X Cap: $27.05B
  • View BIIB Profile
  • View Questions on BIIB
• Gilead Sciences Inc. (GILD $130.40)
  • $130.40 P/E (TTM): 19.74X Cap: $161.88B
  • View GILD Profile
  • View Questions on GILD
• Regeneron Pharmaceuticals Inc. (REGN $751.57)
  • $751.57 P/E (TTM): 18.47X Cap: $79.45B
  • View REGN Profile
  • View Questions on REGN
• Vertex Pharmaceuticals Incorporated (VRTX $430.29)
  • $430.29 P/E (TTM): 28.46X Cap: $109.49B
  • View VRTX Profile
  • View Questions on VRTX
• AbbVie Inc. (ABBV $198.71)
  • $198.71 P/E (TTM): 85.15X Cap: $351.47B
  • View ABBV Profile
  • View Questions on ABBV
• Abbott Laboratories (ABT $91.13)
  • $91.13 P/E (TTM): 24.86X Cap: $158.71B
  • View ABT Profile
  • View Questions on ABT
• Bristol-Myers Squibb Company (BMY $58.71)
  • $58.71 P/E (TTM): 17.06X Cap: $119.87B
  • View BMY Profile
  • View Questions on BMY
• Johnson & Johnson (JNJ $227.50)
  • $227.50 P/E (TTM): 20.91X Cap: $547.64B
  • View JNJ Profile
  • View Questions on JNJ
• Eli Lilly and Company (LLY $883.96)
  • $883.96 P/E (TTM): 39.98X Cap: $835.18B
  • View LLY Profile
  • View Questions on LLY
• Merck & Company Inc. (MRK $111.90)
  • $111.90 P/E (TTM): 15.74X Cap: $276.53B
  • View MRK Profile
  • View Questions on MRK
• Pfizer Inc. (PFE $27.00)
  • $27.00 P/E (TTM): 19.61X Cap: $153.58B
  • View PFE Profile
  • View Questions on PFE

Q: According to Portfolio Analytics, my current allocation to Health Care sector is too low. Here are the names of 12 major US pharmaceutical companies. How would you rank them? If possible, please provide a short comment on each of them: Pfizer, Johnson and Johnson, AbbVie, Amgen, Gilead Sciences, Eli Lilly, Merck, Vertex Pharmaceuticals, Regeneron Pharmaceuticals, Abbott, Biogen, Bristol Myers Squibbs. Thank you

Upvote 8

Read Answer Asked by Gervais on October 30, 2024

• Amgen Inc. (AMGN $344.55)
  • $344.55 P/E (TTM): 24.5X Cap: $185.94B
  • View AMGN Profile
  • View Questions on AMGN
• Regeneron Pharmaceuticals Inc. (REGN $751.57)
  • $751.57 P/E (TTM): 18.47X Cap: $79.45B
  • View REGN Profile
  • View Questions on REGN
• Vertex Pharmaceuticals Incorporated (VRTX $430.29)
  • $430.29 P/E (TTM): 28.46X Cap: $109.49B
  • View VRTX Profile
  • View Questions on VRTX
• Exact Sciences Corporation (EXAS)
  • Cap: $20.02B
  • View EXAS Profile
  • View Questions on EXAS
• iShares Biotechnology ETF (IBB $169.78)
  • $169.78 P/E (TTM): 20.63X Cap: $8.15B
  • View IBB Profile
  • View Questions on IBB
• State Street SPDR S&P Biotech ETF (XBI $133.28)
  • $133.28 P/E (TTM): 17.2X Cap: $8.46B
  • View XBI Profile
  • View Questions on XBI

Q: Hello 5i,

Wondering if you have any recommendations in the Biometrics category, either ETF or stock? And any particular thoughts regarding current valuations and future prospects versus other opportunities?

Thanks for your feedback.

Ralph

Upvote 1

Read Answer Asked by ralph on September 09, 2024

• Costco Wholesale Corporation (COST $1,011.15)
  • $1,011.15 P/E (TTM): 70.49X Cap: $448.59B
  • View COST Profile
  • View Questions on COST
• Alphabet Inc. (GOOG $342.32)
  • $342.32 P/E (TTM): 31.24X Cap: $4.09T
  • View GOOG Profile
  • View Questions on GOOG
• Intuitive Surgical Inc. (ISRG $482.22)
  • $482.22 P/E (TTM): 58.18X Cap: $170.78B
  • View ISRG Profile
  • View Questions on ISRG
• Microsoft Corporation (MSFT $424.62)
  • $424.62 P/E (TTM): 26.0X Cap: $3.15T
  • View MSFT Profile
  • View Questions on MSFT
• Vertex Pharmaceuticals Incorporated (VRTX $430.29)
  • $430.29 P/E (TTM): 28.46X Cap: $109.49B
  • View VRTX Profile
  • View Questions on VRTX
• American Tower Corporation (REIT) (AMT $178.21)
  • $178.21 P/E (TTM): 33.21X Cap: $83.11B
  • View AMT Profile
  • View Questions on AMT
• Eli Lilly and Company (LLY $883.96)
  • $883.96 P/E (TTM): 39.98X Cap: $835.18B
  • View LLY Profile
  • View Questions on LLY
• NextEra Energy Inc. (NEE $95.28)
  • $95.28 P/E (TTM): 29.17X Cap: $198.69B
  • View NEE Profile
  • View Questions on NEE
• Quanta Services Inc. (PWR $624.84)
  • $624.84 P/E (TTM): 93.15X Cap: $93.76B
  • View PWR Profile
  • View Questions on PWR
• Bank of Nova Scotia (The) (BNS $103.54)
  • $103.54 P/E (TTM): 19.98X Cap: $127.61B
  • View BNS Profile
  • View Questions on BNS
  • View Reports on BNS
• BCE Inc. (BCE $32.63)
  • $32.63 P/E (TTM): 4.86X Cap: $30.42B
  • View BCE Profile
  • View Questions on BCE
• Constellation Software Inc. (CSU $2,410.80)
  • $2,410.80 P/E (TTM): 74.64X Cap: $51.08B
  • View CSU Profile
  • View Questions on CSU
  • View Reports on CSU
• Dollarama Inc. (DOL $169.72)
  • $169.72 P/E (TTM): 35.95X Cap: $46.32B
  • View DOL Profile
  • View Questions on DOL
• Agnico Eagle Mines Limited (AEM $273.41)
  • $273.41 P/E (TTM): 22.19X Cap: $136.97B
  • View AEM Profile
  • View Questions on AEM
• Alimentation Couche-Tard Inc. (ATD $76.74)
  • $76.74 P/E (TTM): 19.51X Cap: $70.49B
  • View ATD Profile
  • View Questions on ATD
• Hydro One Limited (H $58.28)
  • $58.28 P/E (TTM): 26.18X Cap: $34.95B
  • View H Profile
  • View Questions on H
• Nutrien Ltd. (NTR $97.86)
  • $97.86 P/E (TTM): 32.77X Cap: $47.16B
  • View NTR Profile
  • View Questions on NTR
• Crocs Inc. (CROX $102.32)
  • $102.32 Cap: $5.12B
  • View CROX Profile
  • View Questions on CROX
• Catalyst Pharmaceuticals Inc. (CPRX $27.37)
  • $27.37 P/E (TTM): 16.38X Cap: $3.34B
  • View CPRX Profile
  • View Questions on CPRX

Q: Hi group can you help me sort out your top2 buys in each sector cw rating the sector(1-10) 10 being the highest. Also rate the recommended buys (1to 10 cw entry target price )

- Power infrastructure , Bio Tech, Health care, Financials, Tech, utilities, Commodities, Power infrastructure , Consumer staples, Consumer discretionary, Communication Thanks for your help.

Upvote 31

Read Answer Asked by Terence on May 28, 2024

• Intuitive Surgical Inc. (ISRG $482.22)
  • $482.22 P/E (TTM): 58.18X Cap: $170.78B
  • View ISRG Profile
  • View Questions on ISRG
• Vertex Pharmaceuticals Incorporated (VRTX $430.29)
  • $430.29 P/E (TTM): 28.46X Cap: $109.49B
  • View VRTX Profile
  • View Questions on VRTX
• Danaher Corporation (DHR $177.25)
  • $177.25 P/E (TTM): 34.54X Cap: $125.45B
  • View DHR Profile
  • View Questions on DHR
• Johnson & Johnson (JNJ $227.50)
  • $227.50 P/E (TTM): 20.91X Cap: $547.64B
  • View JNJ Profile
  • View Questions on JNJ
• Eli Lilly and Company (LLY $883.96)
  • $883.96 P/E (TTM): 39.98X Cap: $835.18B
  • View LLY Profile
  • View Questions on LLY
• Align Technology Inc. (ALGN $189.61)
  • $189.61 P/E (TTM): 33.75X Cap: $13.57B
  • View ALGN Profile
  • View Questions on ALGN

Q: I've held JNJ for over 15 years based on my belief in the quality of their management. I'm feeling my trust may now be overly 'generous' and it may be time to move on, particularly now that the steadiness of consumer products is gone. I'm considering VRTX or another suggestion you could offer. I have full positions in TMO, SYK and UNH, highlighting my preference for quality.

Upvote 8

Read Answer Asked by Mike on April 19, 2024

• Vertex Pharmaceuticals Incorporated (VRTX $430.29)
  • $430.29 P/E (TTM): 28.46X Cap: $109.49B
  • View VRTX Profile
  • View Questions on VRTX
• Eli Lilly and Company (LLY $883.96)
  • $883.96 P/E (TTM): 39.98X Cap: $835.18B
  • View LLY Profile
  • View Questions on LLY
• Novo Nordisk A/S (NVO $41.17)
  • $41.17 P/E (TTM): 10.66X Cap: $363.68B
  • View NVO Profile
  • View Questions on NVO

Q: Opinion Please? Might this be a way to play the weight loss drug trend? Do you have other healthcare suggestions?

Upvote 2

Read Answer Asked by Colleen on March 25, 2024

• Vertex Pharmaceuticals Incorporated (VRTX $430.29)
  • $430.29 P/E (TTM): 28.46X Cap: $109.49B
  • View VRTX Profile
  • View Questions on VRTX

Q: Hi, Could you give us your opinion on Vertex, specially after release of its earnings, yesterday. How is the growth trajectory and pipeline ? Does the recent pull back, notably after the earnings, today, presents a good opportunity to initiate a new position ? Thank You

Upvote 2

Read Answer Asked by rajeev on February 07, 2024

• Vertex Pharmaceuticals Incorporated (VRTX $430.29)
  • $430.29 P/E (TTM): 28.46X Cap: $109.49B
  • View VRTX Profile
  • View Questions on VRTX

Q: Do you see anything on your freindly Bloomberg that tells you the reason VRTX is falling in the past week.

Thanks


Sheldon

Upvote 2

Read Answer Asked by Sheldon on November 15, 2023

• Amgen Inc. (AMGN $344.55)
  • $344.55 P/E (TTM): 24.5X Cap: $185.94B
  • View AMGN Profile
  • View Questions on AMGN
• Regeneron Pharmaceuticals Inc. (REGN $751.57)
  • $751.57 P/E (TTM): 18.47X Cap: $79.45B
  • View REGN Profile
  • View Questions on REGN
• Vertex Pharmaceuticals Incorporated (VRTX $430.29)
  • $430.29 P/E (TTM): 28.46X Cap: $109.49B
  • View VRTX Profile
  • View Questions on VRTX
• Mettler-Toledo International Inc. (MTD $1,282.45)
  • $1,282.45 P/E (TTM): 30.07X Cap: $25.96B
  • View MTD Profile
  • View Questions on MTD

Q: Which company(s) would be a good way to play biotech via the picks and shovels method (A, TMO, etc.)? Thanks

Upvote 0

Read Answer Asked by Michael on September 14, 2022

• Vertex Pharmaceuticals Incorporated (VRTX $430.29)
  • $430.29 P/E (TTM): 28.46X Cap: $109.49B
  • View VRTX Profile
  • View Questions on VRTX

Q: would appreciate your outlook and comments on biotech firm VERTEX.
are their primary products reletively safe and expected to do well?
Ed

Upvote 0

Read Answer Asked by ed on August 18, 2022

• Amgen Inc. (AMGN $344.55)
  • $344.55 P/E (TTM): 24.5X Cap: $185.94B
  • View AMGN Profile
  • View Questions on AMGN
• Regeneron Pharmaceuticals Inc. (REGN $751.57)
  • $751.57 P/E (TTM): 18.47X Cap: $79.45B
  • View REGN Profile
  • View Questions on REGN
• Vertex Pharmaceuticals Incorporated (VRTX $430.29)
  • $430.29 P/E (TTM): 28.46X Cap: $109.49B
  • View VRTX Profile
  • View Questions on VRTX
• iShares Biotechnology ETF (IBB $169.78)
  • $169.78 P/E (TTM): 20.63X Cap: $8.15B
  • View IBB Profile
  • View Questions on IBB
• Mettler-Toledo International Inc. (MTD $1,282.45)
  • $1,282.45 P/E (TTM): 30.07X Cap: $25.96B
  • View MTD Profile
  • View Questions on MTD
• Solid Biosciences Inc. (SLDB $7.92)
  • $7.92 Cap: $826M
  • View SLDB Profile
  • View Questions on SLDB
• TCR2 Therapeutics Inc. (TCRR)
  • View TCRR Profile
  • View Questions on TCRR
• NextCure Inc. (NXTC $10.52)
  • $10.52 Cap: $42M
  • View NXTC Profile
  • View Questions on NXTC

Q: In an answer today you stated '20% of biotech companies in the US now trading below cash levels'. What would be your top biotech picks and/or your top biotech ETFs to play a recovery?

Upvote 0

Read Answer Asked by Larry M. on May 11, 2022

• Amgen Inc. (AMGN $344.55)
  • $344.55 P/E (TTM): 24.5X Cap: $185.94B
  • View AMGN Profile
  • View Questions on AMGN
• Regeneron Pharmaceuticals Inc. (REGN $751.57)
  • $751.57 P/E (TTM): 18.47X Cap: $79.45B
  • View REGN Profile
  • View Questions on REGN
• Vertex Pharmaceuticals Incorporated (VRTX $430.29)
  • $430.29 P/E (TTM): 28.46X Cap: $109.49B
  • View VRTX Profile
  • View Questions on VRTX
• AbbVie Inc. (ABBV $198.71)
  • $198.71 P/E (TTM): 85.15X Cap: $351.47B
  • View ABBV Profile
  • View Questions on ABBV
• Eli Lilly and Company (LLY $883.96)
  • $883.96 P/E (TTM): 39.98X Cap: $835.18B
  • View LLY Profile
  • View Questions on LLY
• Pfizer Inc. (PFE $27.00)
  • $27.00 P/E (TTM): 19.61X Cap: $153.58B
  • View PFE Profile
  • View Questions on PFE
• Mettler-Toledo International Inc. (MTD $1,282.45)
  • $1,282.45 P/E (TTM): 30.07X Cap: $25.96B
  • View MTD Profile
  • View Questions on MTD

Q: Hi, can you suggest some names in Biotech sector with 3-5 year time frame.

Upvote 0

Read Answer Asked by Harpinder on April 21, 2022

• Sernova Biotherapeutics Inc. (SVA $0.17)
  • $0.17 Cap: $59M
  • View SVA Profile
  • View Questions on SVA
• Amgen Inc. (AMGN $344.55)
  • $344.55 P/E (TTM): 24.5X Cap: $185.94B
  • View AMGN Profile
  • View Questions on AMGN
• Regeneron Pharmaceuticals Inc. (REGN $751.57)
  • $751.57 P/E (TTM): 18.47X Cap: $79.45B
  • View REGN Profile
  • View Questions on REGN
• Vertex Pharmaceuticals Incorporated (VRTX $430.29)
  • $430.29 P/E (TTM): 28.46X Cap: $109.49B
  • View VRTX Profile
  • View Questions on VRTX
• Profound Medical Corp. (PRN $9.55)
  • $9.55 Cap: $347M
  • View PRN Profile
  • View Questions on PRN

Q: I have dabbled in a few mid to small cap Canadian bio companies over the years. I never have the stomach to hold on for the long term in general due to high volatility but I like the sector. I'm currently sitting on Sernova (SVA) for now at least. How Do you like them? Do you have any other recommendations in this sector?

Upvote 0

Read Answer Asked by DAVE on March 02, 2022

• Amgen Inc. (AMGN $344.55)
  • $344.55 P/E (TTM): 24.5X Cap: $185.94B
  • View AMGN Profile
  • View Questions on AMGN
• Regeneron Pharmaceuticals Inc. (REGN $751.57)
  • $751.57 P/E (TTM): 18.47X Cap: $79.45B
  • View REGN Profile
  • View Questions on REGN
• Vertex Pharmaceuticals Incorporated (VRTX $430.29)
  • $430.29 P/E (TTM): 28.46X Cap: $109.49B
  • View VRTX Profile
  • View Questions on VRTX
• Mettler-Toledo International Inc. (MTD $1,282.45)
  • $1,282.45 P/E (TTM): 30.07X Cap: $25.96B
  • View MTD Profile
  • View Questions on MTD

Q: I'm hearing that pharma and biotech company valuations are at multi year lows. With one chart showing the percentage of US biotechs with market caps below cash value is at a 25 year high, and by a wide margin. Do you feel this sector shows a big opportunity to get good companies for cheap in a sector that will one day improve? If so what companies look best to you in Canada or US? Are there any sectors that are more beaten up? Thx

Upvote 0

Read Answer Asked by Adam on February 23, 2022

• Vertex Pharmaceuticals Incorporated (VRTX $430.29)
  • $430.29 P/E (TTM): 28.46X Cap: $109.49B
  • View VRTX Profile
  • View Questions on VRTX

Q: Is Vertex Pharmaceuticals Incorporated a good buy at this time to add to a portfolio to start a small position? What do you think of the financial ratios for this stock, their industry that they serve, their customer base and insider ownership? Buy, hold or sell? Thanks

Upvote 0

Read Answer Asked by James on December 18, 2021

• Vertex Pharmaceuticals Incorporated (VRTX $430.29)
  • $430.29 P/E (TTM): 28.46X Cap: $109.49B
  • View VRTX Profile
  • View Questions on VRTX

Q: Thoughts, comments, concerns, recommendations. I am concerned they only have 1 solid drug with relatively narrow application, all beit, important but sitting on considerable cash. Not sure what else may be in the trials pipeline.

Upvote 0

Read Answer Asked by Steven on July 09, 2021

• Cisco Systems Inc. (CSCO $89.01)
  • $89.01 P/E (TTM): 31.87X Cap: $351.57B
  • View CSCO Profile
  • View Questions on CSCO
• NVIDIA Corporation (NVDA $208.27)
  • $208.27 P/E (TTM): 40.74X Cap: $5.06T
  • View NVDA Profile
  • View Questions on NVDA
• QUALCOMM Incorporated (QCOM $148.85)
  • $148.85 P/E (TTM): 27.01X Cap: $158.82B
  • View QCOM Profile
  • View Questions on QCOM
• Vertex Pharmaceuticals Incorporated (VRTX $430.29)
  • $430.29 P/E (TTM): 28.46X Cap: $109.49B
  • View VRTX Profile
  • View Questions on VRTX
• AbbVie Inc. (ABBV $198.71)
  • $198.71 P/E (TTM): 85.15X Cap: $351.47B
  • View ABBV Profile
  • View Questions on ABBV
• Bank of America Corporation (BAC $52.05)
  • $52.05 P/E (TTM): 13.88X Cap: $371.93B
  • View BAC Profile
  • View Questions on BAC
• Stryker Corporation (SYK $327.51)
  • $327.51 P/E (TTM): 39.15X Cap: $125.43B
  • View SYK Profile
  • View Questions on SYK
• Truist Financial Corporation (TFC $50.73)
  • $50.73 P/E (TTM): 13.46X Cap: $62.95B
  • View TFC Profile
  • View Questions on TFC

Q: I have a small USA portfolio consisting of these darlings which I've held for approx. 3 yrs. It's like watching a snail race. Can you recommend a replacement or two for each? I've done OK with SYK and was in good shape with Vertex until last October. Take as many Q credits as needed.

Upvote 0

Read Answer Asked by Carl on January 19, 2021